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Panel (TEP) met to develop and discuss the recom-
mendations and research agenda. For each developed
recommendation i) the level of evidence and grade of
recommendation were determined, and ii) the level of
agreement among TEP members was set. A recom-
mendation was adopted if approved by ≥75% of the
TEP members, and the level of agreement was consid-
ered high when ≥8. All relevant national societies were
included in this construction process to attain their en-
dorsement.   
Results: Based on evidence and expert opinion, the
TEP developed and agreed on five overarching princi-
ples and 12 recommendations for non-pharmacologi-
cal and non-surgical interventions in patients with RA.
The mean level of agreement between the TEP mem-
bers ranged between 8.5 and 9.9. The recommenda-
tions include a broad spectrum of intervention areas,
such as exercise, hydrokinesiotherapy, psychological
interventions, orthoses, education, general manage-
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AbstrAct
Background: Patients with rheumatoid arthritis (RA)
report significant levels of disease impact, which are
improved, but not fully abrogated by immunosup-
pressive therapy, even when remission is achieved. This
imposes the need for adjuvant interventions targeting
the uncontrolled domains of disease impact. Non-phar-
macological interventions are widely used for this pur-
pose, but they have not been the object of profession-
al recommendations or guidelines.
Objective: To propose multidisciplinary recommen-
dations to inform clinical care providers regarding the
employment of non-pharmacological and non-surgical
interventions in the management of patients with RA.
Methods: The EULAR standardized operating proce-
dures for the development of recommendations were
followed. First, a systematic literature review was per-
formed. Then, a multidisciplinary Technical Expert
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ment of comorbidities, among others; and they set the
requirements for their application.
Conclusions: These recommendations are based on
the consensus judgment of clinical experts from a wide
range of disciplines and patients’ representatives from
Portugal. Given the evidence for effectiveness, feasi-
bility and safety, non-pharmacological and non-surgi-
cal interventions should be an integral part of standard
care for people with RA. It is hoped that these recom-
mendations should be widely implemented in clinical
practice. The target audience for these recommenda-
tions includes all health professionals involved in the
care of patients with RA. The target patient population
includes adult Portuguese people with RA.
Keywords: Non-pharmacological interventions;
Rheumatoid arthritis; Portugal; Recommendations.
bAckground
The management of rheumatoid arthritis (RA) has
changed considerably over the past two decades under
the influence of new drugs (such as biological agents)
and new treatment strategies1-4. The current paradigm
of RA treatment is epitomized by the Treat-to-Target
(T2T) strategy, which establishes that remission is the
core therapeutic target and should be achieved as ear-
ly and as permanently as possible. Remission of the
disease, ie complete abrogation of inflammatory activi -
ty, provides the best possible conditions to reduce suf-
fering, stop joint damage, prevent disability, and im-
prove quality of life in the long-term1,2,5,6.
Remission has a markedly positive impact upon pa-
tient reported outcomes2, 5, 7-10. However, a considera -
ble proportion (14 to 38%) of patients with RA are not
in remission only due to a high patient global assess-
ment (PGA) of disease activity and, still report signifi -
cant levels of disease impact, similar to those described
by patients with active disease11-15. This so called “PGA-
-near-remission” status typifies a frequent failure of the
treatment strategy aimed at controlling the disease pro-
cess in achieving the ultimate goal of therapeutic in-
tervention: the enjoyment of life16. These patients can-
not be improved by additional immunosuppressive
therapy, but rather require the introduction of ad-
junctive interventions targeting the uncontrolled do-
mains of disease impact17.
The optimal care of patients with RA imposes, there-
fore, the need for an integrated approach, targeting
both the biological remission and the remission of the
impact upon patients’ lives: the dual-target strategy17.
This will require both pharmacological and non-phar-
macological interventions18, ideally in the context of a
multidisciplinary team16,19,20. However, there are cur-
rently no recommendations regarding the use of inter-
ventions adjunctive to immunosuppressive therapy in
RA21-23. Besides, it is important to understand how pa-
tients perceive remission24 and how they prioritize
treatment outcomes25, since it may affect nonaccep-
tance or nonadherence to treatment goals and proto-
cols9, and even to non-pharmacological interventions26.
The aim of this paper is to propose multidisciplinary
recommendations to inform clinical care providers re-
garding the employment of non-pharmacological and
non-surgical interventions in the management of pa-
tients with RA.
Its evidence base was essentially provided by a re-
cently performed umbrella review27 of the effectiveness
of such interventions upon the seven main domains of
impact of RA identified by patients: pain, functional
disability, fatigue, emotional well-being, sleep, coping,
and physical well-being28.
Methods
To develop these recommendations, a set of rigorous
steps were taken, based on the EULAR standardized
operating procedures29.
1st step – systeMAtic review
A systematic literature review (SLR), specifically an um-
brella review [30] was conducted by the proponents of
this project (EJFS, CD, RJOF and JAPS) following the
Joanna Briggs Institute methodology27. It aimed at de-
termining the effectiveness of non-pharmacological and
non-surgical interventions upon the impact of RA and
included studies of adult patients in any context. The
search strategy was applied to 13 bibliometric databa -
ses and grey literature (CINAHL Plus with Full Text,
PubMed, Cochrane Database of Systematic Reviews,
Scopus, Embase, PsycINFO, PEDro, Epistemonikos,
JBI Database of Systematic Reviews and Implementation
Reports, the PROSPERO register, Campbell Collabora-
tion Library of Systematic Reviews, RCAAP – Repo -
sitório Científico de Acesso Aberto de Portugal; Open-
Grey – System for Information on Grey Literature in
Europe). It included interventions of any form, dura-
tion, frequency and intensity, alone or in combination,
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and rewording. Adoption of each statement required
the approval of at least 75% of the TEP members. If
majority was not reached, changes were introduced un-
til the agreement of ¾ of the participants was achieved.
Additional literature searches were conducted where
the evidence provided by the SLR was considered con-
tradictory or insufficient (e.g. hydrotherapy/bal-
neotherapy interventions are general, unspecific, and
have contradictory evidence, and more specific and
sensitive literature searches were needed for the case of
hydrokinesiotherapy).
At last, each TEP member was asked to rate the le -
vel of agreement (LoA) with each statement, indepen-
dently and anonymously on a numeric rating scale
(0=totally disagree, 10= totally agree) through an on-
line survey. The mean and SD were calculated. A mean
LoA≥ 8 was considered ‘high’. A draft version of this pa-
per was circulated and revised by TEP members until
consensus was achieved.
3rd step – AcceptAnce oF recoMMendAtions 
The recommendations were sent to all previously in-
volved associations (Sociedade Portuguesa de Reuma-
tologia - SPR, SPMFR, APPSReuma, LPCDR and AN-
DAR) for public consultation of their members.   
They were asked to express any critical views re-
garding clarity, content or omissions. The final version
was improved with these inputs.
4th step – endorseMent by scientiFic 
societies
The article incorporating the views of TEP members
was sent to the Portuguese Society of Rheumatology
(SPR), the Portuguese Society for Physical Medicine
and Rehabilitation (SPMFR), the Portuguese Associa-
tion of Health Professionals in Rheumatology (APP-
SReuma), the Portuguese League Against Rheumatic
Diseases (LPCDR) and the National Association of Pa-
tients with Rheumatoid Arthritis (ANDAR) for en-
dorsement.
results
The TEP agreed on five overarching principles and 12
recommendations for non-pharmacological and non-
-surgical interventions in the management of RA, based
on SLR and expert opinion. High LoA was achieved for
all recommendations. Table I summarizes the overar-
ching principles and recommendations with their as-
designed to reduce the impact of the disease. The out-
comes considered were pain, functional disability, fa-
tigue, emotional well-being, sleep, coping, physical
well-being and global impact of disease. Critical ap-
praisal of reports was conducted independently by two
reviewers (ES and CD), using the Joanna Briggs Insti-
tute critical appraisal checklist for systematic reviews
and research syntheses. Data extraction was also per-
formed independently by two reviewers and data was
summarized using a tabular format with supporting
text (for detailed methodology see Santos EJF et al.27).
The results were organized in a summary of findings
using The Grading of Recommendations, Assessment,
Development and Evaluation (GRADE) which provides
an approach to grading quality of evidence based on
risk of bias, heterogeneity, indirectness, imprecision
and publication bias31. 
2nd step – Focused technicAl expert pAnel
(tep) on rA
The focused TEP on RA included the proponents, four
rheumatologists, two specialist physicians represent-
ing the Portuguese Society for Physical Medicine and
Rehabilitation (SPMFR), four representative members
of the Portuguese Association of Health Professionals in
Rheumatology (APPSReuma; one nurse, one physical
therapist, one psychologist and one occupational thera -
pist), all with extensive experience in clinical care and
research in the field of RA. These health professionals
(HPs) were nominated as representatives for this pur-
pose by their respective scientific societies. Rheuma-
tologists were individually invited on the basis of ex-
pertise in this field. All involved societies endorsed the
final versions of this manuscript. This TEP also incor-
porated two patients, representing the Portuguese
League Against Rheumatic Diseases (LPCDR) and the
National Association of Patients with Rheumatoid
Arthritis (ANDAR). As requirements, patients had to
understand English, had to have more than 10 years of
disease duration (RA) and had been treated with at least
one biological agent.
TEP members received the results of the SLR and
were asked to individually draft overarching principles
(background statements to preface recommendations),
recommendations, and research agenda points. These
proposals were compiled and aggregated into a first
draft of statements for consensual evaluation during a
plenary meeting, where the final overarching princi-
ples, recommendations, and research agenda were con-
sensualized through an iterative process of discussion
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tAble i. recoMMendAtions For non-phArMAcologicAl And non-surgicAl interventions in people
with rheuMAtoid Arthritis
LoE* GoR† LoA (0-10)
Overarching principles
A. The primary goal of non-pharmacological and non-surgical interventions in - - 9.9 (0.3)
RA is to assist patients in maximizing their overall quality and enjoyment of life, 
through optimized control of the impact of disease, besides and beyond 
medications and surgery.
B. Patients must be given a decisive role in establishing the objectives and the - - 9.7 (0.6)
nature of interventions in their particular case, in an informed and shared 
decision-making process.
C. The healthcare team must make sure that the patient has all the information - - 9.8 (0.5)
deemed relevant to support his/her participation in self-care and in 
shared-decision making, including the short and long-term outlook of the disease 
and of the available scope of treatments and interventions.
D. Non-pharmacological and non-surgical interventions demand the involvement - - 9.8 (0.5)
of a multiprofessional/ multidisciplinary team, and the adoption of an holistic 
bio-psycho-social model. 
E. Non-pharmacological and non-surgical interventions should be selected on the - - 9.9 (0.5)
basis of the available evidence and adjusted to the patient’s specific clinical 
features, abilities, preferences and needs.
Recommendations
1. Non-pharmacological and non-surgical interventions should be an integral 1a A 9.6 (0.7)
part of standard care in people with RA and should be considered throughout the 
course of the disease, whenever they may provide relevant, objective or 
subjective, benefit to the patient, as adjuvant or as an alternative to symptomatic  
medication or surgery.
2. Areas of intervention to be considered in this context include, but are not 5 D 9.2 (1.3)
limited to: self-management, pain relief, energy management, joint alignment and 
support, thermotherapy, exercise, hydrokinesiotherapy, psychological interventions, 
daily leisure and work activities, education, family involvement, social participation 
and social care, sleep hygiene and general management of comorbidities.
3. Dedicated educational programs and supporting materials should be made 1a B 9.8 (0.6)
available to patients, providing information on the general aspects of the disease 
and its management, their role in the shared-care process and the specificities of 
common assessments and interventions.
4. Patients should be regularly inquired for unmet needs, through the use of 2b B 9.1 (1.4)
validated large-scope instruments, and referenced to the most appropriate health 
professional(s) in the team.
5. The multiprofessional team must try to make interventions as attractive and 2b B 9.8 (0.5)
relevant as possible to patients, as a mean to ensure the best possible adherence 
and long-term effectiveness.
6. Interventions should be targeted to specific objectives that are relevant to the 3 C 9.6 (0.7)
individual patients, regularly monitored with validated instruments and adapted 
accordingly.
7. All patients should be stimulated to follow a personalized and regular 1a B 9.7 (0.7)
physical exercise program to reduce pain, functional disability, fatigue and global 
impact of disease.
Continues on the next page
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sociated level of evidence, grade of recommendation
and LoA. A Portuguese translated version of the rec-
ommendations is also provided (Table Ia - annex).
Recommendation 1: Non-pharmacological and non-
surgical interventions should be an integral part of
standard care in patients with RA and should be con-
sidered throughout the course of the disease, when-
ever they may provide relevant, objective or subjec-
tive, benefit to the patient, as adjuvant or as an
alternative to symptomatic medication or surgery.
Given the evidence for effectiveness, feasibility and
safety, non-pharmacological and non-surgical inter-
ventions should be an integral part of the standard of
care for patients with RA. Non-pharmacological and
non-surgical interventions are effective in reducing
pain, functional disability, fatigue and the global im-
pact of RA21, 27, 32-38, but they are not expected to change
the disease process.
Our umbrella review included 8 SLR with a total of
91 RCTs and 9 observational studies (6740 partici-
pants) and showed that multicomponent or single ex-
ercise/physical activity, orthoses and psychosocial in-
terventions have the highest level of evidence and grade
of recommendation27. Feasibility of interventions mea-
sured by adherence has been reported in 75% of the
studies, and generally rated as moderate to high27, 39.
Non-pharmacological and non-surgical interventions
are safe, since no detrimental effects were reported, ex-
cept for minor joint or muscle pain after exercise27, 39.
On this basis, non-pharmacological and non-surgi-
cal interventions should be considered as adjuvant
measures or as an "alternative" to symptomatic medi-
cation or surgery, with the exception of  disease modi-
fying interventions, and only when relevant benefit to
the patient (either objective or subjective) can reason-
ably be expected26. 
Recommendation 2: Areas of intervention to be con-
sidered in this context include, but are not limited to:
self-management, pain relief, energy management,
joint alignment and support, thermotherapy, exercise,
hydrokinesiotherapy, psychological interventions,
daily leisure and work activities, education, family in-
volvement, social participation and social care, sleep
hygiene and general management of comorbidities.
Non-pharmacological interventions include a diverse
set of techniques, strategies and practices described in
the literature21, 27, 32-38, 40-43. This recommendation aims
at widening the health professionals’ perspective when
tAble i. continuAtion
LoE* GoR† LoA (0-10)
8. Hydrokinesiotherapy should be considered, to reduce pain and global impact 2b B 9.2 (1.0)
of disease.
9. Orthoses should be considered as a mean to reduce joint pain, functional 1a B 9.1 (1.1)
disability and global impact of disease.
10. Psychosocial interventions should be considered as a mean to reduce pain, 1a B 9.6 (0.9)
functional disability, fatigue and global impact of disease.
11. The prevention and management of comorbidities and adverse effects of all 3 C 9.8 (0.5)
types of interventions should be part of the multiprofessional team goals.
12. Commonly used non-pharmacological interventions, without solid 5 D 8.5 (1.5)
experimental evidence support may be considered in individual patients, if and 
only if: i) there is no reasonable and proven alternative; ii) they have merited 
consensual approval by qualified health professionals; iii) they are safe and 
accepted by a duly informed patient.
These recommendations should be interpreted in the light of the clarifications provided in the body of the text and by the supporting SLR.
*1a: systematic review of RCTs; 1b: individual RCT; 2a: systematic review of cohort studies; 2b: individual cohort study (including 
low-quality RCT; eg,<80% follow-up); 3a: systematic review of case-control studies; 3b: individual case-control study; 4: case-series (and
poor quality cohort and case-control studies); 5: expert opinion without explicit critical appraisal, or based on physiology, bench research 
or ‘first principles’. † A: based on consistent level 1 evidence; B: based on consistent level 2 or 3 evidence or extrapolations from level 1
evidence; C: based on level 4 evidence or extrapolations from level 2 or 3 evidence; D: based on level 5 evidence or on troublingly
inconsistent or inconclusive studies of any level. LoE, level of evidence; GoR, grade of recommendation; LoA, level of agreement. 
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considering all that can be done, beyond medication
and surgery, to assist patients with RA in pursuing their
personal goals and a better quality of life. 
Recommendation 3: Dedicated educational programs
and supporting materials should be made available to
patients, providing information on the general aspects
of the disease and its management, their role in the
shared-care process and the specificities of common
assessments and interventions.
Patient education is recommended as an integral part
of the standard of care44 and comprises all educational
activities provided for patients and their supporters
(families and care-providers), including aspects of ther-
apy, health care and health promotion45
Several cross-sectional and qualitative studies ex-
ploring patients’ needs and expectations described a
wide range of educational needs, such as knowledge
on management of the disease, side effects and risk fac-
tors, non-pharmacological treatment, pain control and
self-help methods46-51.
Patient education should be provided by HPs with
specific competencies and training and should be tai-
lored to the individual patient’s needs, in order to in-
crease and qualify the patients’ involvement in shared-
care decisions44, 52, 53.
Special attention should be given to health promo-
tion in general and for specific areas, such as smoking
cessation. A recent study confirmed that smoking is a
strong risk factor for developing seropositive RA and
demonstrated, for the first time, that sustained smok-
ing cessation could delay or even prevent seropositive
RA54. In addition, RA patients with a history of smok-
ing are more likely to have a poor response to biologi-
cal medication55-57. Therefore, smoking status should
be determined and smoking cessation should be en-
couraged58. Patients’ organizations may be active part-
ners in the development of educational interventions
and/or in the dissemination of educational materials.
Recommendation 4: Patients should be regularly in-
quired for unmet needs, through the use of validated
large-scope instruments, and referenced to the most
appropriate health professional(s) in the team.
Despite progress in medication, several unmet needs
still have a negative impact on patient’s personal expe-
rience of RA59, 60. In order to minimize this, patients
should be regularly inquired for unmet needs, by
means of validated large-scope instruments27. Cur-
rently, in our opinion, the most suitable instrument for
this purpose is the Rheumatoid Arthritis Impact of Dis-
ease Score (RAID)28, 61 which was developed with pa-
tients and considers seven different domains of impact:
pain, functional disability, fatigue, emotional well-be-
ing, physical well-being, sleep and coping. RAID has
been extensively validated as a combined index of over-
all impact. The scales it uses to assess individual do-
mains of disease impact are valid, feasible, reliable and
sensitive to change in patients with RA61, 62, also specif-
ically for the Portuguese patients63. Using the 7 scores
separately (RAID.7i) also offers a feasible tool to anal-
yse impact of disease and to select and monitor indi-
vidually tailored interventions, targeting the domains
of concern.
Multidisciplinary collaborative work seems essential to
provide the best service for patients. In our umbrella re-
view, the following HPs were reported to have provid-
ed relevant interventions: medical doctors, nurses,
physical therapists, psychologists, occupational thera-
pists, counselors, dieticians, and other professionals,
namely, yoga teachers21, 27, 36. However, as the functions,
responsibilities and individual career paths of HPs vary
across Europe64, referral should be carried out to the
professional that is best qualified and positioned to de-
liver the best quality of care65.
Recommendation 5: The multiprofessional team must
try to make interventions as attractive and relevant as
possible to patients, as a mean to ensure the best pos-
sible adherence and long-term effectiveness.
Low adherence is a prevalent and persistent healthcare
problem, also in RA patients66-68. Patients need to be
motivated to adhere to all proposed interventions and
these should be adjusted, individualized and ex-
plained, in order to serve that purpose27. The multi-
disciplinary team should consider the different modes
of intervention delivery: supervised vs not-supervised,
individual vs groupal, face to face vs remote, commu-
nity/home-based vs  hospital-centred, and try to adjust
to the patients preferences and resources27. Increasing
adherence to therapy is essential to improve the effica-
cy of treatments and reduce costs68. Patients’ organiza-
tions should be active stakeholders in promoting ad-
herence, collaborating in the development of
interventions and/or disseminating motivation strate-
gies.
Dedicated interventions targeting adherence should be
considered in cases where non-adherence is anticipat-
ed. These interventions aim to change the patient’s be-
havior by shifting his/her thoughts, feelings, confidence
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or motivation to adhere. They can vary widely in con-
tent and include techniques and skill-based instruc-
tions to enhance patients’ sense of self-efficacy, moti-
vation, ownership and problem-solving skills66, 69. 
Recommendation 6: Interventions should be targeted
to specific objectives that are relevant to the individ-
ual patients, regularly monitored with validated in-
struments and adapted accordingly.
Non-pharmacological interventions should target well-
defined and explicit individual goals, which should be
regularly monitored with validated instruments, in-
cluding patient reported outcomes measures (PROMs).
These instruments should have been demonstrated as
reliable, transculturally valid and meaningful to pa-
tients and HPs70. Specifically, physical exercise should
be routinely assessed for exercises domains (cardiores-
piratory, muscle strength, flexibility and neuromotor)
and by performance-based tests71. Specific tools have
been described for these purposes39, but we have not
evaluated their validity or reliability. 
Patients should be instructed on the purpose and in-
terpretation of the measurements, and advised to use
them proactively to discuss the treatment plan and re-
sults with the multidisciplinary team72.
Recommendation 7: All patients should be stimulated
to follow a personalized and regular physical exer-
cise program to reduce pain, functional disability, fa-
tigue and global impact of disease.
Exercise has been endorsed as a measure to promote
health in general39 but it is ignored by recommenda-
tions on the treatment of inflammatory arthritis, with
few exceptions71.
Multicomponent or single exercise/physical activity in-
terventions have a small to moderate beneficial effect
for patients with RA in improving pain, functional dis-
ability, fatigue and in reducing the global impact of dis-
ease21, 27, 32-34, 41. The studied interventions comprise re-
sistance, strengthening, aerobic and flexibility
exercises. Reported studies are extremely variable, in-
cluding multicomponent or single modalities and a
large array of frequencies (1-5 sessions per week), du-
ration (10 min-4.5 hours per session) and intensity
(30-100% of an individual’s maximum heart rate)27.
There is no evidence to support the selection of the best
modality or to guide its adaptation to individual
needs21, 27. 
Exercise programs should be adapted based on a com-
prehensive individual assessment and adjusted to the
individual patient s abilities, specificities (age, gender,
comorbidities, mobility loss…) and preferences27, 71.
For this reason, the prescription of exercise should be
made by a qualified and experienced professional. Pro-
fessional supervision of the exercise is preferable, but
unsupervised exercises can and should be promoted,
especially if this is crucial to ensure adherence27, 39, 71. 
To improve acceptance and long-term adherence to
physical exercise, group and/or individual maintenance
programs should be promoted33, 67. The combination
of exercise and psychosocial interventions can also pro-
vide better overall outcomes21, 27.
In addition to the exercise programs mentioned above,
we found evidence that Tai chi and occupational ther-
apy have also beneficial effects for patients with RA.
Particularly, Tai chi has demonstrated benefits on low-
er extremity range of motion73, and occupational ther-
apy has been shown to improve functional ability, so-
cial participation and quality of life40.
Recommendation 8: Hydrokinesiotherapy should be
considered, to reduce pain and global impact of dis-
ease.
Evidence regarding the use of hydrotherapy/ bal-
neotherapy for pain, functional disability and global
impact of disease is scarce and contradictory27, 37, 74. This
is mainly due to the lack of standardization of the in-
terventions administered and most studies have im-
portant limitations and low quality27. However, it is im-
portant to note that some recent evidence supports the
benefits of hydrokinesiotherapy and radon-carbon
dioxide baths in reducing pain and enhancing quality
of life75-77.
Recommendation 9: Orthoses should be considered as
a mean to reduce joint pain, functional disability and
global impact of disease.
Orthoses have a moderate beneficial effect in improv-
ing pain, functional disability and quality of life in peo-
ple with RA27, 38, 78-80.
They include standard orthoses, custom orthoses, sil-
icone orthosis, technical adaptations to over-the-
counter shoes, ready or custom-made therapeutic
shoes, or a provisional therapy (e.g., felt padding or
taping) and has been advocated for patients with ab-
normal function, joint damage/deformity, or malalign-
ment of the hand, ankle, foot or other joints27, 38, 42, 78-80.
It seems important that the management of deformity
starts in an early stage of the disease, to reduce pain
and activity limitations, and to prevent the deteriora-
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tion of function42, 81. Orthoses should be used through-
out the progression of the disease in cases of abnormal
function, joint damage/deformity, or malalignment,
and even for feet that do not fit in over-the-counter
shoes or ready-made therapeutic shoes, not just as a
means of preventing deformities42, 80, 81.
The first multidisciplinary recommendations specific
to the management of foot problems in patients with
RA have recently been published80.
Recommendation 10: Psychosocial interventions
should be considered as a mean to reduce pain, func-
tional disability, fatigue and global impact of disease.
Psychosocial interventions have a small beneficial effect
in improving pain, functional disability and fatigue in
patients with RA21, 27, 36, 82, 83. Published studies comprise
a diverse set of methods and interventions, including
expressive writing, cognitive skills training, cognitive
behavioral therapy, mindfulness, lifestyle management,
self-management, energy conservation, contracting/
goal setting, coping, guided imagery and self-instruc-
tion, among others21, 36. Naturally, this implies consi -
deration of the specific principles and methods of
appli cation of each intervention, and that they must be
selected and adjusted according to the individual pa-
tient’s situation21, 27, 36, 82, 83. However, the information
serving this purpose is scarce.
Recommendation 11: The prevention and manage-
ment of comorbidities and adverse effects of all types
of interventions should be part of the multiprofes-
sional team goals.
It is well known that people with RA have an increased
prevalence of numerous comorbidities, such as car-
diovascular risk factors, osteoarthritis, depression and
osteoporosis, among others84-87 and this represents a
demanding challenge for HPs88. Patients with RA and
multimorbidity are at risk of insufficient care on both
dimensions of their health and present poorer patient-
reported outcomes84. 
To achieve better outcomes, we suggest that the
management of comorbidities and adverse effects
should be recognized by HPs and patients and explic-
itly included in the program covered by these recom-
mendations. The promotion of healthy lifestyles, with
emphasis on smoking cessation, is of paramount im-
portance in this context. These interventions are sup-
ported by several recommendations or points to con-
sider58, 89.
Recommendation 12: Commonly used non-pharma-
cological interventions, without solid experimental
evidence support may be considered in individual pa-
tients, if and only if: i) there is no reasonable and
proven alternative; ii) they have merited consensual
approval by qualified health professionals; iii) they
are safe and accepted by a duly informed patient.
There is a diversity of interventions that are common-
ly used in practice, despite the lack of solid published
evidence. Many are supported by a small number of
poorly standardized investigations. For example, ther-
motherapy is commonly used but evidence is limited.
Superficial moist heat and cryotherapy can be used but
only paraffin wax baths combined with exercises can be
recommended for beneficial short-term effects for
arthritic hands on the basis of evidence43. Evidence for
acupuncture is also very limited mainly due to the poor
quality and small sample size of studies. However, elec-
troacupuncture may be beneficial to reduce symp-
tomatic knee pain in patients with RA90. Low level
laser therapy (Classes I, II and III) has been associated
with short-term treatment for relief of pain and morn-
ing stiffness91.
Electrical stimulation was shown to have a clinical-
ly beneficial effect on grip strength and fatigue resis-
tance for RA patients with muscle atrophy of the
hand92. Regarding the use of transelectrical nerve stim-
ulation (TENS), a particular type of electrical stimula-
tion that is thought to produce analgesia according to
the gate control theory, conflicting effects on pain out-
comes were reported in RA93.
Ultrasound often used by rehabilitation specialists
based on expected anti-inflammatory and analgesic
properties, have been shown to decrease morning stiff-
ness and reduce the number of painful joints94.
At last, although there is conflicting evidence when
studying specific dietary regimes, it is recognized that
nutrition, in general, should not be neglected. In this
sense, all patients should be stimulated to follow a per-
sonalized, diversified and balanced diet95, 96.
Using interventions that do not have a robust sup-
port in the published literature, ensuring that the sci-
entific and clinical contraindications to their use are
recognized, entails a possible risk of non-benefit for
both the patient and the health professional, that needs
to be acknowledged and accepted by both parties. The
lack of evidence precludes that formal recommenda-
tions can be made in favor or against the use of these
interventions. The decision is left in the hands of the
HPs, preferably shared with the multiprofessional team,
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but the general rules established in this recommenda-
tion should be respected.
Research agenda
A research agenda was developed and is presented in
Table II. Additionally, a Portuguese translated version
was also provided (Table IIa - annex).
Acceptance of recommendations
We promoted a public consultation of the recommen-
dations among all members of the involved associa-
tions. Comments were received from 20 persons, in-
cluding 6 rheumatologists, 5 nurses, 3 general
physicians, 3 physiatrists, 2 nutritionists and 1 patient.
All respondents expressed full agreement with the con-
tent and clarity of the recommendations and pointed
out few omissions and/or suggestions. The final ver-
sion was improved with these inputs.
discussion
These are the first multidisciplinary recommendations
for non-pharmacological and non-surgical interven-
tions in patients with RA.  
Limitations on the evidence base serving these re -
commendations significantly impact their wording and
assertiveness - this must be acknowledged upfront. Be-
sides being limited in number and scope, published
studies frequently have low methodological quality, in-
cluding a poor characterization of the diagnostic crite-
ria, the interventions and conditions of application
and/or the outcome measures18, 27. For many specific
non-pharmacological interventions, evidence is almost
totally absent. Additionally, the criteria for classifying
the disease have changed over time to encompass ear-
lier disease classifications, and modern treatments and
strategies have changed the face of RA and of patients’
needs97, 98.  Despite this, non-pharmacological and non-
surgical interventions are widely used and play an im-
portant role in the management of RA worldwide, un-
derlining the need for recommendations to guide
practice and research, in the best interests of the pa-
tient.
The five overarching principles and 12 recommen-
dations represent the consensualized perspective of the
TEP members, representing different professional and
personal backgrounds, based on the available evidence
and on personal experience. A high LoA was reached
in all cases. 
These recommendations are targeted at all health
professionals who care for patients with RA. The pub-
lication of the complete SLR, including a detailed des -
cription of its methodology and results, provides the in-
tAble ii. reseArch AgendA For non-phArMAcologicAl And non-surgicAl interventions in people
with rheuMAtoid Arthritis
1. To carry out well-designed RCTs in areas where evidence is scarce, poorly qualified and/or contradictory (e.g.
hydrotherapy, physical agents such as electrotherapy and others).
2. To study other relevant outcomes, such as physical and emotional well-being, sleep and coping, in addition to pain,
function and fatigue.
3. To evaluate short and long-term effectiveness.
4. To assess the most effective type of exercises, optimal method of delivery, intensity and frequency.
5. To assess which and how different components or interventions should be combined and their interaction effects.
6. To identify disease-specific contraindications.
7. To assess the design of orthosis (material, which joints are supported…).
8. To define the desired content of education.
9. To investigate the optimal design and delivery of psychosocial interventions.
10. To study the feasibility and efficacy of maintenance programs or boost sessions to ensure long-term adherence and
maintain therapeutic gains over time.
11. To perform cost-effectiveness studies.
12. To determine the optimal strategies to implement these recommendations in different settings.
13. To identify facilitators and barriers of health professionals towards applying these interventions and
recommendations.
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terested reader with a full update of the currently avail-
able evidence27. However, it should be noted that ad-
ditional searches were conducted where the evidence
provided by the SLR was considered contradictory or
insufficient. Therefore, it is important to note that the
recommendations presented in Table I cannot be cor-
rectly interpreted and used without the accompanying
text and the supporting SLR.
Efforts to implement these recommendations will be
made by dissemination across national societies, on-
line platforms and by presentations in leading interna-
tional congresses and educational sessions. However,
we recognize that due to differences in healthcare sys-
tems and particularities of each country, it will be
proba bly necessary to further develop, adapt and eva -
luate national or regional implementation strategies.
The presented research agenda (Table II) highlights
several areas where scientific evidence is lacking and/or
scarce. 
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Annex
tAble ia. recoMendAÇÕes pArA intervencoes nÃo-FArMAcolÓgicAs e nÃo-cirÚrgicAs eM pessoAs
coM Artrite reuMAtÓide
NE* GR† NC (0-10)
A. O principal objetivo das intervenções não-farmacológicas e não cirúrgicas na - - 9,9 (0,3)
AR é ajudar os doentes a maximizar a sua qualidade de vida em geral e a 
satisfação com a vida, através do controlo otimizado do impacto da doença, além 
e para além da medicação e da cirurgia.
B. Os doentes devem ter um papel decisivo no estabelecimento dos objetivos - - 9,7 (0,6)
e da natureza das intervenções no seu caso particular, numa decisão informada 
e partilhada.
C. A equipa de saúde deve certificar-se de que o doente possui toda a informação - - 9,8 (0,5)
considerada relevante para apoiar a sua participação no autocuidado e no processo 
de decisão partilhada, incluindo as perspetivas de curto e longo prazo da doença 
e do âmbito do tratamento e intervenções disponíveis.
D. As intervenções não-farmacológicas e não cirúrgicas exigem o envolvimento - - 9,8 (0,5)
de uma equipa multiprofissional/multidisciplinar, e a adoção de um modelo 
bio-psico-social holístico.
E. As intervenções não farmacológicas e não cirúrgicas devem ser selecionadas - - 9,9 (0,5)
com base nas evidências disponíveis e ajustadas às características clínicas, 
capacidades, preferências e necessidades específicas do doente.
Continues on the next page
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NE* GR† NC (0-10)
Recomendações
1. As intervenções não farmacológicas e não cirúrgicas devem ser parte integrante 1a A 9,6 (0,7)
do padrão de cuidados em pessoas com AR e devem ser consideradas ao longo 
do curso da doença, sempre que possam proporcionar benefícios relevantes, 
objetivos ou subjetivos ao doente, como adjuvante ou alternativa à medicação 
ou cirurgia sintomática.
2. As áreas de intervenção a serem consideradas neste contexto incluem, mas não 5 D 9,2 (1,3)
se limitam a: autogestão, alívio da dor, gestão da energia, alinhamento e suporte 
articular, termoterapia, exercício, hidrocinesioterapia, intervenções psicológicas, 
atividades diárias, de lazer e trabalho, educação, envolvimento familiar, participação 
social e cuidados sociais, higiene do sono e gestão geral das comorbilidades.
3. Devem ser disponibilizados aos doentes programas educacionais dedicados e 1a B 9,8 (0,6)
materiais de apoio, fornecendo informações sobre os aspetos gerais da doença e 
a sua gestão, o seu papel no processo de cuidados partilhados e as especificidades 
das avaliações e intervenções comuns.
4. Os doentes devem ser questionados regularmente sobre necessidades não 2b B 9,1 (1,4)
satisfeitas, através da utilização de instrumentos validados de grande alcance, 
e referenciados ao(s) profissional(is) de saúde mais adequado(s) da equipa.
5. A equipa multiprofissional deve tentar tornar as intervenções tão atrativas e 2b B 9,8 (0,5)
relevantes quanto possível para os doentes, como forma de assegurar a melhor 
adesão possível e eficácia a longo prazo.
6. As intervenções devem ser orientadas para objetivos específicos que sejam 3 C 9,6 (0,7)
relevantes para os objetivos individuais do doente, monitorizadas regularmente 
com instrumentos validados e adaptadas em conformidade.
7. Todos os doentes devem ser estimulados a seguir um programa regular de 1a B 9,7 (0,7)
exercício físico personalizado para reduzir a dor, incapacidade funcional, fadiga 
e impacto global da doença.
Princípios gerais
8. A hidrocinesioterapia deve ser considerada para reduzir a dor e o impacto 2b B 9,2 (1,0)
global da doença.
9. As ortóteses devem ser consideradas como um meio para reduzir a dor articular, 1a B 9,1 (1,1)
a incapacidade funcional e o impacto global da doença.
10. As intervenções psicossociais devem ser consideradas como um meio de 1a B 9,6 (0,9)
reduzir a dor, a incapacidade funcional, a fadiga e o impacto global da doença.
11. A prevenção e gestão de comorbilidades e efeitos adversos de todos os tipos 3 C 9,8 (0,5)
de intervenções deve fazer parte dos objetivos da equipa multiprofissional.
12. Intervenções não farmacológicas comumente utilizadas, sem evidências 5 D 8,5 (1,5)
experimentais sólidas, podem ser consideradas em doentes individuais, se e 
somente se: i) não houver alternativa razoável e comprovada; ii) tiverem 
merecido aprovação consensual por profissionais de saúde qualificados; 
iii) forem seguras e aceites por um doente devidamente informado.
Estas recomendações devem ser interpretadas à luz dos esclarecimentos fornecidos no corpo do texto e pelo RSL de apoio.
* 1a: revisão sistemática dos Ensaios Clínicos Aleatorizados e Controlados (ECACs) ; 1b: ECAC individual; 2a: revisão sistemática dos
estudos de coorte; 2b: estudo de coorte individual (incluindo ECACs de baixa qualidade; por exemplo,<80% de follow-up); 3a: revisão
sistemática dos estudos de caso-controlo; 3b: estudo de caso-controlo individual; 4: série de casos (e estudos de coorte e caso-controlo de
baixa qualidade); 5: opinião de especialistas sem avaliação crítica explícita, ou baseada em fisiologia, pesquisa experimental/ “ciência básica”
ou "primeiros princípios". † A: baseado em evidência consistente de nível 1; B: baseado em evidência consistente de nível 2 ou 3 ou
extrapolações de evidência de nível 1; C: baseado em evidência de nível 4 ou extrapolações de evidência de nível 2 ou 3; D: baseado em
evidência de nível 5 ou em estudos inconsistentes ou inconclusivos de qualquer nível. NE, Nível de Evidência; GR, Grau de Recomendação;
NC, Nível de Concordância. 
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tAble iia. AgendA de investigAÇÃo pArA intervenÇÕes nÃo FArMAcolÓgicAs e nÃo cirÚrgicAs eM
pessoAs coM Artrite reuMAtÓide.
1. Realizar ensaios clínicos bem desenhados em áreas onde as evidências são escassas, pouco qualificadas e/ou
contraditórias (por exemplo, hidroterapia, agentes físicos como eletroterapia e outros).
2. Estudar outros resultados (outcomes) relevantes, tais como o bem-estar físico e emocional, o sono e coping,
adicionalmente à dor, função e fadiga.
3. Avaliar a eficácia a curto e longo prazo.
4. Avaliar os tipos de exercícios mais eficazes, método ótimo de realização, intensidade e frequência.
5. Avaliar quais e como diferentes componentes ou intervenções devem ser combinados e os seus efeitos de interação.
6. Identificar as contraindicações específicas da doença.
7. Avaliar o desenho das ortóteses (material, que articulações são suportadas...)
8. Definir o conteúdo desejado para a educação.
9. Investigar a conceção e realização ótima de intervenções psicossociais.
10. Estudar a viabilidade e eficácia de programas de manutenção ou sessões de reforço para assegurar a adesão a longo
prazo e manter os ganhos terapêuticos ao longo do tempo.
11. Realizar estudos de custo-eficácia.
12. Determinar as estratégias ótimas para implementar estas recomendações em diferentes contextos.
13. Identificar facilitadores e barreiras dos profissionais de saúde para a aplicação destas intervenções e recomendações.
